SurgePays, Inc. Receives Nasdaq Delisting Notice and Issues Shares to CEO
SurgePays, Inc. Receives Nasdaq Delisting Notice and Issues Shares to CEO
Key Points from the Report
- Nasdaq Delisting Notice: SurgePays, Inc. (NASDAQ: SURG) has received a formal notice from Nasdaq indicating the company is not in compliance with two key continued listing requirements: the Minimum Market Value of Listed Securities (MVLS) and the Minimum Bid Price Requirement.
- Compliance Deadlines: The company has 180 calendar days, until September 14, 2026, to regain compliance with the MVLS requirement, and until September 21, 2026, to regain compliance with the Bid Price Requirement.
- Immediate Impact: The notice does not immediately affect the trading or listing of SurgePays’ securities. However, a compliance indicator will be displayed on Nasdaq.com and related market data platforms to inform investors of the deficiency.
- Potential Consequences of Delisting: If SurgePays fails to regain compliance, its securities will be subject to delisting from Nasdaq. This could significantly reduce liquidity, market price, and the company’s ability to raise capital or offer equity incentives.
- Unregistered Issuance of Shares: On or about March 23, 2026, the company issued 800,000 shares of common stock to CEO Brian Cox at \$1.25 per share in satisfaction of a \$1,000,000 debt, as part of a previously issued promissory note. The shares were issued with standard transfer restrictions under the Securities Act of 1933.
Details Shareholders Need to Know
- Nasdaq Compliance and Delisting Risk:
- SurgePays failed to meet Nasdaq’s minimum standards for both the market value of its listed securities and the minimum bid price. If the company does not rectify these deficiencies by the stated deadlines, it risks being delisted from the Nasdaq Capital Market.
- Delisting would have serious effects, including:
- Reduced liquidity and potentially lower share price.
- Fewer investors might be willing or able to trade the shares.
- The company’s ability to raise funds through public capital markets could be impaired.
- Restrictions on using equity as employee incentives.
- Issuance of Shares to CEO:
- 800,000 shares were issued to CEO Brian Cox at \$1.25 per share, in satisfaction of \$1 million in debt.
- This transaction was not registered under the Securities Act and was done as a private transaction with standard transfer restrictions.
- The issuance could potentially dilute existing shareholders, although it also relieves the company of \$1 million in debt to its CEO.
- Forward-Looking Statements:
- The report contains forward-looking statements regarding the company’s efforts to regain Nasdaq compliance, and whether the company’s stock will remain listed. These statements are subject to significant risks and uncertainties, and actual outcomes could differ materially.
Potential Price-Sensitive Issues for Investors
- Delisting Risk: Any development regarding the company’s compliance with Nasdaq listing standards is highly price-sensitive. Delisting could materially impact the share price, trading volume, and investor sentiment.
- Insider Transactions: The issuance of a large block of shares to the CEO, even in satisfaction of debt, is material and could affect the share price due to dilution concerns.
Summary Table
| Event |
Details |
Potential Impact |
| Nasdaq Delisting Notice |
Non-compliance with MVLS and Bid Price Requirements |
Risk of delisting, lower liquidity, reduced ability to raise capital |
| Deadline to Regain Compliance |
Sept 14, 2026 (MVLS), Sept 21, 2026 (Bid Price) |
If not met, shares may be delisted |
| Share Issuance to CEO |
800,000 shares at \$1.25/share to satisfy \$1M debt |
Possible dilution, but reduces company debt |
Conclusion
The notice of non-compliance from Nasdaq and the large share issuance to the CEO are both highly material events for SurgePays, Inc. shareholders. Investors should closely monitor the company’s actions to regain compliance and the impact of the new shares on ownership and potential dilution. If the company fails to regain compliance, a delisting could substantially affect the value and tradability of SurgePays shares.
Disclaimer: The information provided above is a summary of disclosures made by SurgePays, Inc. in its Form 8-K filing. This article does not constitute investment advice. Investors should perform their own due diligence and consult with their financial advisors before making investment decisions. Forward-looking statements are subject to risks and uncertainties and actual results may differ materially.
View SurgePays, Inc. Historical chart here
